Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. [Phase 1]

View source ↗

Summary

Early-phase Phase 1 trial to evaluate the safety, tolerability, and pharmacokinetics of BSY001 after single and multiple doses; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cowpox
• Monkeypox
• Smallpox

Drugs mentioned

• BSY001 (BSY001)

Snippet

Sponsor: China National Biotec Group Company Limited | Conditions: Smallpox, Cowpox | Phase 1 | Status: RECRUITING